The intestinal phase of gastric secretion has been thought to be due to the release of a hormone from the gut mucosa, and several properties have been attributed to this as-yet unidentified hormone. An amino acid solution, known to stimulate gastric secretion, was tested to see if it possesses several of these properties, i.e., inactivation by the liver, and the ability to augment the maximum responses to pentagastrin and histamine. In six dogs with Heidenhain pouches the gastric secretory responses to peripheral and portal intravenous administration of a solution of mixed L-amino acids were measured. The mean peak response of three such separate peripheral infusions in each dog was 370 microEq/30 minutes while the peak response to intraportal infusion was only 45 microEq/30 minutes (p < .05). In three dogs with Heidenhain pouches the intravenous administration of amino acids together with pentagastrin resulted in significant augmentation of the peak response to pentagastrin alone (p < .025). Similarly, administration of amino acids with histamine resulted in augmentation of the peak response to histamine alone (p < .05). Because amino acids mimic the actions of the "intestinal phase hormone" in these respects it is suggested that they may account, at least in part, for the intestinal phase of gastric secretion. In addition, amino acids absorbed during protein digestion may contribute to the gastric hypersecretion which is regularly seen with portosystemic shunts.
SUMMARY Gastric secretory dose-response studies, using an 8.5 % mixed L-amino acid solution as the agonist, were carried out in three dogs with Heidenhain pouches and gastric fistulae. Secretory responses of the Heidenhain pouches were measured during two hour infusions of amino acids given at rates of 0, 0.05, 0.1, 0-2, 0.4, 0.8, and 1.6 g/kg/h and plasma amino nitrogen was measured before and during the infusion. 4 September 1979 were performed aseptically with the dogs fully anaesthetised, and a recovery period of three to four weeks was allowed before secretory studies were undertaken. The studies were carried out after an 18 hour fast, during which water was allowed, and were repeated no more often than thrice weekly. With the dogs in modified Pavlov stands, an intravenous solution of 0.9% NaCI was begun. Secretion from the pouches was collected each 30 minutes and the H+ion content was determined; secretion from the main stomach was allowed to drain externally and was discarded. After a basal collection period of 60 minutes the test solution was administered by a peristaltic pump at a constant infusion rate for two hours. The test solution consisted of an 8.5% solution of mixed L-amino acids (Freamine II, McGaw Laboratories) given at a dose of 0.05, 0.1. 0.2, 0.4, 0.8, or 1.6 g/kg/h or of a solution of 0.9% sodium chloride (control) given at 30 ml/h. Only one dose was given on each test day and the order in which the various doses was given was randomised. Three tests at each dose, as well as three control infusions, were made in each dog. Blood was taken during the basal period and at 30 and 90 minutes after start of the test infusion. After centrifugation, the plasma was frozen and stored at -20C for subsequent amino nitrogen determinations by the method of Goodwin.7When the dose which gave the maximum response had been determined, a second series of experiments was carried out to ensure that hyperosmolarity of 91 on 10 May 2018 by guest. Protected by copyright.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.